Empower Cervical 1/ ENGOT-Cx9/ GEICO 72-C/ GOG-3016

Trial Description: 
An Open Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator’s Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Cervical
Trial Status: 
Recruiting
Contact person: